Journals / Nöropsikiyatri Arşivi / 2010 / Cilt: 47 - Sayı: 3

Geniş lif nöropatisi olmayan Tip II diabetes mellituslu hastalarda ince lif hasarının kantitatif duyusal test ile değerlendirilmesi ve termal şik normal değerleri

The evaluatione of small nerve fiber dysfunction with quantitative sensory testing in patients with type II diabetes mellitus without large fiber neuropathy, and normal values for thermal thresholds

Pages
223–229
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because of its subjectivity and inefficacy in differentiation of peripheral and central causes, QST findings should be evaluated together with findings of neurological examination and nerve conduction studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Quantitative sensory testing (QST) thermal threshold evaluation is used in order to determine small fiber neuropathy, and the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale is used in diagnosing neuropathic pain.
📊
Key Findings & Data:Methods: A total of one hundred normal subjects between the ages of 20 and 69, and 50 patients with type II diabetes mellitus aged 40 to 69 years with no sign of large fiber neuropathy were recruited.
💡
Conclusion & Impact:Because of its subjectivity and inefficacy in differentiation of peripheral and central causes, QST findings should be evaluated together with findings of neurological examination and nerve conduction studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Quantitative sensory testing (QST) thermal threshold evaluation is used in order to determine small fiber neuropathy, and the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale is used in diagnosing neuropathic pain. The aim of this study is to find out the normal QST thermal threshold values, and to compare the QST values of normal controls and patients with type II diabetes mellitus, who do not have large fiber neuropathy. With this comparison, the study also aims to determine whether QST abnormalities are present in patients without neuropathic pain. Methods: A total of one hundred normal subjects between the ages of 20 and 69, and 50 patients with type II diabetes mellitus aged 40 to 69 years with no sign of large fiber neuropathy were recruited. The normal subjects were divided into 5 subgroups according to their ages. The mean values of the QST thermal detection and thermal pain thresholds were determined. Sixty normal subjects between the ages of 40-69 were defined as a control group for comparison with the diabetic group. The patients were divided into subgroups according to their LANSS points and their data were compared with the data of age-matched controls. Results: The mean ages of total normal subjects and the control group were 44.8±14.4 and 57.4±8.4, respectively. In diabetic group, according to LANSS, 10 patients (mean age, 55.1±8.5 years) scored above 12 (14.6 ± 3.5), and 40 patients (mean age, 55.5±8.4 years) scored under 12 points (6.8±3.4). In the LANSS>12 group, the least abnormality rate was 100 %, and the most frequently detected abnormality was in the foot cold pain threshold (70%). In the LANSS<12 group, the least abnormality rate was 67.5%, and the most frequently detected abnormality was in the hand cold pain threshold (45%). Conclusion: It was demonstrated that QST was successful in determining thermal detection abnormalities in all patients with probable neuropathic pain according to LANSS Pain Scale. QST is a test, which gives reliable and reproducible results in the diagnosis of small fiber sensory neuropathy. Because of its subjectivity and inefficacy in differentiation of peripheral and central causes, QST findings should be evaluated together with findings of neurological examination and nerve conduction studies.

Özet

Amaç: Kantitatif duyusal test (QST) termal eşik değerlendirmesi ince lif nöropatisinin tespitinde, LANSS skalası da nöropatik ağrı tanısında kullanılmaktadır. Bu çalışmada kalın lif nöropatisi olmayan tip II diyabetes mellituslu olgularda iki inceleme birlikte yapılarak, uyumlu sonuçlar verip vermedikleri, birbirlerine üstünlüklerinin olup olmadığının araştırılması ve laboratuvarımızın değişik yaş gruplarına ait QST termal eşik değerlerinin tespit edilmesi amaçlanmıştır. Yöntemler: 20-69 yaş arası kadın ve erkek 100 normal birey ve kalın lif nöropatisi saptanmayan 50 tip II diyabetes mellituslu hasta çalışmaya alınmıştır. 20-69 yaş arasında 5 normal grup belirlenmiş ve normal QST termal algı ve termal ağrı algısı ortalamaları saptanmıştır. 40-69 yaş arasında 60 normal birey, diyabetik grupla karşılaştırmak üzere kontrol grubu olarak kullanılmıştır. LANSS skalasına göre nöropatik ağrı tanısı alanlar ve almayanların verileri, yaşları uyumlu kontrol grubu verileri ile karşılaştırılmıştır. Bulgular: Normal bireylerin ve kontrol grubunun yaş ortalamaları 44.8±14.4 ve 54.7±8.4’dür. Diyabetik grupta yaş ortalaması 55.1±8.5 olan 10 kişi LANSS skalasında>12’nin üzerinde puan almış (14.6 ± 3.5), yaş ortalaması 55.5±8.4 olan 40 kişinin LANSS puanı 12’nin altında kalmıştır (6.8±3.4). LANSS>12 grubunda, en az bir anormallik saptanma oranı % 100 bulunmuş, en fazla anormallik ayak soğuk ağrı algısında saptanmıştır (% 70). LANSS<12 grubunda en az bir anormallik saptanma oranı % 67.5 olarak belirlenmiş ve en fazla anormallik el soğuk ağrı algısında bulunmuştur (% 45). Sonuç: QST, LANSS skalası ile 12’den fazla puanı olan büyük olasılıkla nöropatik ağrı tanısı alanlarda termal algı anormalliklerinin varlığını göstermekte başarılı bulunmuştur. QST, ince lif nöropatisi ve nöropatik ağrı tanısında güvenilir ve tekrar edilebilir sonuçlar veren bir testtir. Subjektivite içermesi, periferik ve santral sebepleri ayırmadaki yetersizlikleri nedeniyle nörolojik muayene ve ileti incelemeleri ile birlikte değerlendirilmelidir.

🔖

Cite This Article

YILDIZ, N., DOĞAN, N., YILDIZ, S., ALTUNRENDE, B., DİKBAŞ, O. (2010). Geniş lif nöropatisi olmayan Tip II diabetes mellituslu hastalarda ince lif hasarının kantitatif duyusal test ile değerlendirilmesi ve termal şik normal değerleri. Nöropsikiyatri Arşivi, Cilt: 47 - Sayı: 3, 223–229. https://ajindex.com/articles/292890

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Backonja MM. Defining neuropathic pain. Anesth Analg 2003; 97:785-90 2. Lacomis D. Small-fiber neuropathy. Muscle Nerve 2002; 26:173-88. 3. Gorson KC, Ropper AH. Idiopathic distal small fiber neuropathy. Acta Neurol Scand 1995; 92:376-82. 4. Bennett MI, Attal N, Backonja MM et al. Using screening tools to identify neuropathic pain. Pain 2007; 127:199-203. 5. Yucel A, Senocak M, Kocasoy Orhan E et al. Results of the Leeds assessment of neuropathic symptoms and signs pain scale in Turkey: a validation study. J Pain 2004; 5:427-32. 6. Uludağ B. Nöropatik Ağrı Değerlendirmesinde Elektrofizyolojik Yöntemler. Sendrom 2008;(Suppl 3):30-6. 7. Neeling JN, Beks PJ, Bertelsmann FW et al. Sensory thresholds in older adults: reproducibility and reference values. Muscle Nerve 1994; 17:454-61. 8. Yarnitsky D, Sprecher E, Zaslansky R et al. Heat pain thresholds: normative data and repeatability. Pain 1995; 60:329-32. 9. Gelber DA, Pfeifer MA, Broadstone VL et al. Components of variance for vibratory and thermal thresholds testing in normal and diabetic subjects. J Diabetes Complications 1995; 9:170-6. 10. Fruhstorfer J, Lindblom U, Schmidt WC. Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 1976; 39:1071-5 11. Cruccu G, Anand P, Attal N et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004; 11:153-62. 12. Holland NR, Crawford TO, Hauer P et al. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998; 44:47-59. 13. Periquet MI, Novak V, Collins MP et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 1999; 53:1641-7. 14. Tobin K, Giuliani MJ, Lacomis D. Comparison of different modalities for detection of small fiber neuropathy. Clin Neurophysiol 1999; 110:1909-12. 15. Novak V, Freimer ML, Kissel JT et al. Autonomic impairment in painful neuropathy. Neurology 2001; 56:861-8. 16. Shy ME, Frohman EM, So YT et al. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003; 60:898-904. 17. Kojo I, Pertovaara A. The effects of stimulus area and adaptation temperature on warm and heat pain thresholds in man. Int J Neurosci 1987; 32:875-80. 18. Dyck PJ, Zimmerman I, Gillen DA et al. Cool, warm, and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptors. Neurology 1993; 43:1500-8. 19. Bartle